Sales Growth YoY (Last 12 Months): senseibio.com (SNSE)

Public company logo of senseibio.com (SNSE)

The year-over-year revenue dynamics for the last 12 months provided by the GURU.Markets system are based on the validation of the TMAb platform for T-cell stimulation for Sensei Biotherapeutics (SNSE). The value 0.00 serves as the current parameter for this process. Consequently, Sensei Biotherapeutics (SNSE) is developing ImmunoPhage to create anti-cancer vaccines, relying exclusively on its internal pipeline and academic partnerships without engaging in M&A transactions.

Sensei Bio (SNSE) Revenue Growth YoY (Last 12 Months): for the period 02/11/2024 - 06/16/2026

Sensei Biotherapeutics (SNSE) - metric breakdowns and financial figures

- market price and analyst price targets:
- company stock exchange capitalization indicators:
Summary company analytics:Sensei Biotherapeutics
Product sample of Sensei Bio

Sensei Biotherapeutics (SNSE) is optimizing the development of cancer antibodies through AI automation and robotics. This indicator captures the daily change in trailing twelve-month revenue, measuring revenue growth rates in real time. The metric allows investors to assess the business's operational resilience and the impact of currency factors on capital. This analysis helps identify a slowdown in the company's expansion in a timely manner. The dynamics of these processes are clearly reflected in the trend of the LTM sales volume change.

Competitors of Sensei Biotherapeutics (SNSE)

Sales Growth YoY (TTM) NantKwest IBRX|IMCR - Sales Growth YoY (Last Twelve Months)|JANX (januxrx.com) - Sales Growth YoY (Last 12 Months)|Arcus Corp (RCUS) - Sales Growth YoY (Last Twelve Months)|Trailing Twelve Months Revenue Growth Zymeworks Corp (ZYME)|Revenue Growth YoY (Last 12 Months) TNGX|IOVA - Revenue Growth Rate YoY (Last Twelve Months)|Revenue Growth YoY (Last 12 Months) IMTX (Immatics Corp)|Revenue Change YoY (Last 12 Months) XNCR|Sales Growth YoY (TTM) CMPX (Compass Therapeutics, Inc.)|Revenue Dynamics YoY (Last Twelve Months) REPL|lyell.com - Sales Growth YoY (TTM)|Trailing Twelve Months Revenue Growth Innate Pharma S.A|Pyxis (PYXS) - Sales Growth YoY (Last Twelve Months)|Compugen Ltd - Revenue Dynamics YoY (Last Twelve Months)|IOBT (iobiotech.com) - Sales Growth YoY (TTM)|Sales Growth YoY (TTM) Sutro Biopharma Inc.|Sales Growth YoY (Last Twelve Months) MiNK Therapeutics (INKT)|HOWL: Trailing Twelve Months Sales Growth|Immix Biopharma - Revenue Growth YoY (Last 12 Months)|ALX Oncology (ALXO) - Trailing Twelve Months Revenue Growth|CUE: Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Sales Growth PDSB|sonnetbio.com (SONN) - Sales Growth YoY (Last Twelve Months)|MAIA Biotechnology Inc (MAIA) - Sales Growth YoY (TTM)|Sales Growth YoY (Last Twelve Months) liminatuspharma.com|Sales Growth YoY (Last Twelve Months) LVTX|Revenue Growth YoY (Last 12 Months) NXTC (NextCure, Inc.)|LPTX: Trailing Twelve Months Sales Growth|Sales Growth YoY (Last Twelve Months) intensitytherapeutics.com INTS|Annual Revenue Growth (Last Twelve Months) Theriva Biologics, Inc. (TOVX)|GRTS: Revenue Growth YoY (Last 12 Months)|Annual Revenue Growth (Last Twelve Months) kinetabio.com KA|NEXI (neximmune.com) - Revenue Growth YoY (Last 12 Months)|Trailing Twelve Months Revenue Growth Turnstone Biologics Corporation (TSBX)|Revenue Growth YoY (Last 12 Months) VCNX|HARP: Revenue Dynamics YoY (Last Twelve Months)